DNA RNA and Cells

13 Feb 2008 Ophthotech Enrolls Its First Patient in a Phase I Anti-PDGF Macular Degeneration Trial
09 Feb 2008 VGX Pharmaceuticals Announces the IND Filing of VGX-3200, a Novel DNA Therapy That Utilizes GHRH for the Treatment of Cancer Cachexia and Anemia
07 Feb 2008 Alnylam Reports Pre-clinical Progress with RNAi Therapeutics in Neurological Disease
06 Feb 2008 Insception Biosciences Begins Human Clinical Trials of Stem Cell Treatment That Could Replace Bone Marrow Transplants
30 Jan 2008 Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
29 Jan 2008 Topigen Pharmaceuticals Initiates European Phase 2 Clinical Study of TPI ASM8 in Patients with Asthma
23 Jan 2008 Alnylam Reports Positive Phase II Data for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
22 Jan 2008 MolMed gets regulatory approval to start a Phase III trial in Italy of its TK therapy for high risk acute leukaemia
18 Jan 2008 StemCells, Inc. Provides Batten's Clinical Trial Update
18 Jan 2008 Clinical Trial to Treat Rare Skin Disorder With siRNA Technology
11 Jan 2008 Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
08 Jan 2008 Sangamo BioSciences Initiates Phase 2 Clinical Trial of ZFP Therapeutic in Stem Cell Mobilization
08 Jan 2008 Tacere Therapeutics Eenters Collaborationa and License Agreement With Pfizer to Develop and Commercilize RNAi Hepatitis C Drug
07 Jan 2008 Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
27 Dec 2007 Leiden University Medical Center and Prosensa B.V. Announce New England Journal of Medicine Publication of First Successful Clinical Study with RNA-based Therapeutic PRO051 in Duchenne Muscular Dystrophy
20 Dec 2007 Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
18 Dec 2007 Year-end clinical trial update
18 Dec 2007 Epeius Biotechnologies gains commercial approval for Rexin-G(R), a tumor-targeted gene-based medicine for metastatic cancer
13 Dec 2007 Alnylam Reports Continued Progress in Clinical Development of ALN-RSV01 for the Treatment of Respiratory Syncytial Virus (RSV) Infection
13 Dec 2007 Oxford biomedica initiates Phase I/II trial of prosavin (R) gene-based treatment for parkinson's disease
12 Dec 2007 Gene A/S begins Phase Ib clinical trial with NsG0202 for the treatment of Alzheimer's disease
12 Dec 2007 Ceregene Presents Long-Term Follow-Up from Phase 1 Trial of CERE-120 in Parkinson's Disease
12 Dec 2007 NeuroSearch's associated company NsGene A/S starts Phase Ib clinical study with NsG0202 for the treatment of Alzheimer's disease
10 Dec 2007 Sangamo BioSciences Announces Presentation of Data for ZFP Therapeutic for Glioblastoma at American Society for Hematology Meeting
10 Dec 2007 Osiris Therapeutics Reports Positive Results for Prochymal(TM) as

La Merie Biologics

FREE Weekly News Bulletin

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing